NOVARTIS ANIMAL HEALTH
Novartis Animal Health is a leader in developing new and better ways to prevent and treat diseases in pets, farm animals and farmed fish. Their innovative, high-quality medicines contribute to the quality of life, health and welfare of animals around the world. They focus on developing new products and technologies to meet the diverse needs of pet owners, veterinarians, farmers and fish farmers now and in the future. Their scientists strive to improve animal care and welfare by researching new medicines and novel drug delivery technologies to improve efficacy and ease of use.
NOVARTIS ANIMAL HEALTH
Industry:
Health Care
Founded:
1997-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.ah.novartis.com
Total Employee:
10001+
Status:
Closed
Contact:
+41 31 377 51 11
More informations about "Novartis Animal Health" on Search Engine
Animal Research | Novartis
Novartis fully supports the replacement of animals with non-animal alternatives wherever feasible, while meeting our obligations to patients and the expectations of regulatory โฆSee details»
Elanco | Our Journey
Leading Animal Health. Elanco acquires Novartis Animal Health. The combined organization is committed to leading the animal health industry in delivering innovation โฆSee details»
Lilly Finalizes Novartis Animal Health Acquisition | Eli โฆ
Jan 1, 2015 Under the terms of the agreement, Lilly acquired the Novartis Animal Health business in an all-cash transaction of approximately $5.4 billion, including anticipated tax โฆSee details»
Novartis Animal Health - Crunchbase Company Profile
Novartis Animal Health is a leader in developing new and better ways to prevent and treat diseases in pets, farm animals and farmed fish. Acquired by. Eli Lilly. Basel, Basel-Stadt, โฆSee details»
Elanco Completes Takeover of Novartis Animal Health
January 9, 2015. By Veterinary Practice News Editors. Novartis Animal Health is no more. The division of Swiss-based Novartis AG officially merged with Elanco Animal Health as โฆSee details»
Lilly Announces Agreement to Acquire Novartis Animal โฆ
INDIANAPOLIS, April 22, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire Novartis Animal Health for approximately $5.4 โฆSee details»
Elanco Finalizes Purchase of Novartis Animal Health - Cowsmo
Jan 3, 2015 Elanco today announced it has finalized the acquisition of Novartis Animal Health, creating a new global leader in animal health focused on delivering increased โฆSee details»
Eli Lilly Announces Agreement to Purchase Novartis Animal Health
Hog Health. April 22, 2014. 2 Min Read. Eli Lilly and Company recently announced an agreement to purchase Novartis Animal Health for approximately $5.4 billion in an all โฆSee details»
Novartis Position on Animal Research
Novartis has a Global Animal Welfare Organization that ensures ethical oversight and compliance of Novartis sponsored animal studies and is empowered to steer and โฆSee details»
Elanco Finalizes Purchase of Novartis Animal Health
Eli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of Novartis Animal Health, which will further position Lillyโs Elanco as a global leader in โฆSee details»
Elancoโs acquisition of Novartis Animal Health finalized
Jan 2, 2015 The combined organization will have expanded capabilities and expertise with a broader portfolio of more than 100 product development projects focused on: โฆSee details»
Lilly Finalizes Novartis Animal Health Acquisition - PR Newswire
INDIANAPOLIS, Jan. 1, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of Novartis Animal Health, which will โฆSee details»
Lilly announces agreement to acquire Novartis Animal Health
Apr 28, 2014 Eli Lilly and Co. says it has entered an agreement to acquire Novartis Animal Health (NAH) for approximately $5.4 billion in an all-cash transaction that will โฆSee details»
Eli Lilly acquires Novartis Animal Health for $5.4bn
Jan 5, 2015 US-based Eli Lilly and Company has completed the acquisition of Novartis Animal Health for $5.4bn. Lilly noted the acquisition was funded with $3.4bn cash-on โฆSee details»
Animal Research | novartis
Animal research helps us develop safe new medicines for patients. We are committed to the highest standards of animal welfare.See details»
Elanco Aqua for Enhancing Salmon Health & Performance
In 2001 Novartis Animal Health acquired this business, growing it significantly for 13 years, before becoming part of Elanco Animal Health. In 2020, as a result of the acquisition of โฆSee details»
Fauquier SPCA โ Come And Meet Someone Who Loves You!
Posted on February 6, 2024 by Heather Farmer. Continue reading โ. Posted in Announcement, Special Events.See details»
Elanco Completes Takeover of Novartis Animal Health
Novartis Animal Health is no more. The division of Swiss-based Novartis AG officially merged with Elanco Animal Health as of Jan. 1 in a $5.4 billion sale to Elancoโs parent โฆSee details»
Principal Scientist | Novartis
May 7, 2024 The Preclinical Safety (PCS) department within the Novartis Biomedical Research - Translational Medicine Unit provides non-clinical safety strategy of products โฆSee details»
Lilly Finalizes Novartis Animal Health Acquisition
Jan 1, 2015 Under the terms of the agreement, Lilly acquired the Novartis Animal Health business in an all-cash transaction of approximately $5.4 billion, including anticipated tax โฆSee details»